The MarketWatch News Department was not involved in the creation of this content. -- Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle -- The transaction ...
Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa $7 billion, representing the largest transaction in nuclear ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Curium, a French ...
Curium has established a legal entity in China which represents a major milestone in Curium’s international growth strategy and will enhance Curium’s ability to serve patients with cancer across Asia ...
LONDON, United Kingdom, September 1, 2025 (EZ Newswire) -- In an exclusive interview, opens new tab with The European, opens new tab’s Juliette Foster, Curium Group, opens new tab CEO Renaud Dehareng ...
Curium Biopharma will continue to lead discovery and new product development Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancer Curium ...
The CV values Curium at about $7 billion The transaction includes lead investors ICG, TPG GP Solutions, CVC Secondary Partners and other investors such as Goldman Sachs Alternatives, Lunate, Pantheon, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Also a Blueprint exec has joined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback